Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma from the JAVELIN solid tumor phase 1b trial: Analysis of safety, clinical activity, and PD-L1 expression.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Apolo, AB; Infante, JR; Hamid, O; Patel, MR; Wang, D; Kelly, K; Mega, AE; Britten, CD; Ravaud, A; Mita, AC; Safran, H; Stinchcombe, T; Grote, HJ; von Heydebreck, A; Cuillerot, J-M; Gulley, JL

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • 4514 - 4514

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.4514